Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Head/neck melanoma

This article was originally published in The Gray Sheet

Executive Summary

Sentinel lymph node mapping - a technique that indicates whether cancer cells have spread to proximal lymph nodes and pose a danger of further metastasis - reliably stages nodal basins in head and neck cutaneous melanomas, while maintaining an acceptable level of safety in the complex neck and parotid regions, University of Michigan research team reports in the January Archives of Otolaryngology. The mapping process uses preoperative lymphoscintigraphy and a combination of intraoperative gamma probe and blue dye...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017803

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel